1. Home
  2. AVB vs ROIV Comparison

AVB vs ROIV Comparison

Compare AVB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AVB

AvalonBay Communities Inc.

HOLD

Current Price

$169.54

Market Cap

22.5B

Sector

Real Estate

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.19

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVB
ROIV
Founded
1978
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
20.7B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AVB
ROIV
Price
$169.54
$28.19
Analyst Decision
Hold
Strong Buy
Analyst Count
15
8
Target Price
$198.20
$27.56
AVG Volume (30 Days)
948.5K
4.2M
Earning Date
04-27-2026
05-28-2026
Dividend Yield
4.22%
N/A
EPS Growth
N/A
N/A
EPS
7.40
N/A
Revenue
$3,040,725,000.00
$29,053,000.00
Revenue This Year
$4.04
N/A
Revenue Next Year
$5.03
$878.32
P/E Ratio
$22.76
N/A
Revenue Growth
4.36
N/A
52 Week Low
$160.10
$9.87
52 Week High
$213.34
$30.33

Technical Indicators

Market Signals
Indicator
AVB
ROIV
Relative Strength Index (RSI) 54.61 54.52
Support Level $167.78 $26.45
Resistance Level $181.72 $30.33
Average True Range (ATR) 2.94 0.94
MACD 1.10 0.02
Stochastic Oscillator 91.01 80.38

Price Performance

Historical Comparison
AVB
ROIV

About AVB AvalonBay Communities Inc.

AvalonBay Communities owns a portfolio of 296 apartment communities with more than 90,000 units and is developing 24 additional properties with approximately 8,600 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: